Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2013

Open Access 01-12-2013 | Original investigation

Accumulation of epicardial fat rather than visceral fat is an independent risk factor for left ventricular diastolic dysfunction in patients undergoing peritoneal dialysis

Authors: Heng-Hsu Lin, Jen-Kuang Lee, Chung-Yi Yang, Yu-Chung Lien, Jenq-Wen Huang, Cho-Kai Wu

Published in: Cardiovascular Diabetology | Issue 1/2013

Login to get access

Abstract

Background

Symptoms of heart failure with preserved left ventricular systolic function are common among patients undergoing peritoneal dialysis (PD). Epicardial fat (EpF) is an ectopic fat depot with possible paracrine or mechanical effects on myocardial function. The aim of our current study is to assess the association between EpF and Left ventricular diastolic dysfunction (LVDD) in patients undergoing PD and to clarify the relationships among EpF, inflammation, and LVDD in this population.

Methods

This was a cross-sectional study of 149 patients with preserved left ventricular systolic function who were undergoing PD. LVDD was diagnosed (according to the European Society of Cardiology guidelines) and EpF thickness measured by echocardiography. The patients without LVDD were used as controls. The serum inflammatory biomarker high-sensitivity C-reactive protein (hsCRP) was measured. The location and amount of adipose tissue were assessed by computed tomography (CT) at the level of the fourth lumbar vertebra.

Results

Subjects with LVDD had higher levels of hsCRP, more visceral and peritoneal fat, and thicker EpF (all p < 0.001) than controls. Visceral adipose tissue, hsCRP, and EpF all correlated significantly (p < 0.05) with LVDD. Multivariate regression analysis rendered the relationship between visceral adipose tissue and LVDD insignificant, whereas EpF was the most powerful determinant of LVDD (odds ratio = 2.41, 95% confidence interval = 1.43–4.08, p < 0.01). EpF thickness also correlated significantly with the ratio of transmitral Doppler early filling velocity to tissue Doppler early diastolic mitral annular velocity (E/e’; r = 0.27, p < 0.01).

Conclusion

EpF thickness is significantly independently associated with LVDD in patients undergoing PD and may be involved in its pathogenesis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998, 32: S112-S119. 10.1053/ajkd.1998.v32.pm9820470.CrossRefPubMed Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998, 32: S112-S119. 10.1053/ajkd.1998.v32.pm9820470.CrossRefPubMed
2.
go back to reference Bajraktari G, Berbatovci-Ukimeraj M, Hajdari A, Ibraimi L, Daullxhiu I, Elezi Y, Ndrepepa G: Predictors of increased left ventricular filling pressure in dialysis patients with preserved left ventricular ejection fraction. Croat Med J. 2009, 50: 543-549. 10.3325/cmj.2009.50.543.PubMedCentralCrossRefPubMed Bajraktari G, Berbatovci-Ukimeraj M, Hajdari A, Ibraimi L, Daullxhiu I, Elezi Y, Ndrepepa G: Predictors of increased left ventricular filling pressure in dialysis patients with preserved left ventricular ejection fraction. Croat Med J. 2009, 50: 543-549. 10.3325/cmj.2009.50.543.PubMedCentralCrossRefPubMed
3.
go back to reference Stenvinkel P: Inflammation in end-stage renal disease: the hidden enemy. Nephrology (Carlton). 2006, 11: 36-41. 10.1111/j.1440-1797.2006.00541.x.CrossRef Stenvinkel P: Inflammation in end-stage renal disease: the hidden enemy. Nephrology (Carlton). 2006, 11: 36-41. 10.1111/j.1440-1797.2006.00541.x.CrossRef
4.
go back to reference Wu CK, Yang CY, Lin JW, Hsieh HJ, Chiu FC, Chen JJ, Lee JK, Huang SW, Li HY, Chiang FT, Tsai CT: The relationship among central obesity, systemic inflammation, and left ventricular diastolic dysfunction as determined by structural equation modeling. Obesity (Silver Spring). 2012, 20: 730-737. 10.1038/oby.2011.30.CrossRef Wu CK, Yang CY, Lin JW, Hsieh HJ, Chiu FC, Chen JJ, Lee JK, Huang SW, Li HY, Chiang FT, Tsai CT: The relationship among central obesity, systemic inflammation, and left ventricular diastolic dysfunction as determined by structural equation modeling. Obesity (Silver Spring). 2012, 20: 730-737. 10.1038/oby.2011.30.CrossRef
5.
go back to reference London GM: Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial. 2003, 16: 85-94.CrossRefPubMed London GM: Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial. 2003, 16: 85-94.CrossRefPubMed
6.
go back to reference Ikonomidis I, Nikolaou M, Dimopoulou I, Paraskevaidis I, Lekakis J, Mavrou I, Tzanela M, Kopterides P, Tsangaris I, Armaganidis A, Kremastinos DT: Association of left ventricular diastolic dysfunction with elevated nt-pro-bnp in general intensive care unit patients with preserved ejection fraction: a complementary role of tissue doppler imaging parameters and nt-pro-bnp levels for adverse outcome. Shock. 2010, 33: 141-148. 10.1097/SHK.0b013e3181ad31f8.CrossRefPubMed Ikonomidis I, Nikolaou M, Dimopoulou I, Paraskevaidis I, Lekakis J, Mavrou I, Tzanela M, Kopterides P, Tsangaris I, Armaganidis A, Kremastinos DT: Association of left ventricular diastolic dysfunction with elevated nt-pro-bnp in general intensive care unit patients with preserved ejection fraction: a complementary role of tissue doppler imaging parameters and nt-pro-bnp levels for adverse outcome. Shock. 2010, 33: 141-148. 10.1097/SHK.0b013e3181ad31f8.CrossRefPubMed
7.
go back to reference Fontan MP, Rodriguez-Carmona A, Cordido F, Garcia-Buela J: Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis, and hemodialysis: a comparative analysis. Am J Kidney Dis. 1999, 34: 824-831. 10.1016/S0272-6386(99)70038-7.CrossRefPubMed Fontan MP, Rodriguez-Carmona A, Cordido F, Garcia-Buela J: Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis, and hemodialysis: a comparative analysis. Am J Kidney Dis. 1999, 34: 824-831. 10.1016/S0272-6386(99)70038-7.CrossRefPubMed
8.
go back to reference Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD: Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis. 2004, 43: 1047-1055. 10.1053/j.ajkd.2004.02.017.CrossRefPubMed Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD: Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis. 2004, 43: 1047-1055. 10.1053/j.ajkd.2004.02.017.CrossRefPubMed
9.
go back to reference Jager KJ, Merkus MP, Huisman RM, Boeschoten EW, Dekker FW, Korevaar JC, Tijssen JG, Krediet RT: Nutritional status over time in hemodialysis and peritoneal dialysis. JASN. 2001, 12: 1272-1279.PubMed Jager KJ, Merkus MP, Huisman RM, Boeschoten EW, Dekker FW, Korevaar JC, Tijssen JG, Krediet RT: Nutritional status over time in hemodialysis and peritoneal dialysis. JASN. 2001, 12: 1272-1279.PubMed
10.
go back to reference Choi SJ, Kim NR, Hong SA, Lee WB, Park MY, Kim JK, Hwang SD, Lee HK: Changes in body fat mass in patients after starting peritoneal dialysis. Perit Dial Int. 2011, 31: 67-73. 10.3747/pdi.2009.00131.CrossRefPubMed Choi SJ, Kim NR, Hong SA, Lee WB, Park MY, Kim JK, Hwang SD, Lee HK: Changes in body fat mass in patients after starting peritoneal dialysis. Perit Dial Int. 2011, 31: 67-73. 10.3747/pdi.2009.00131.CrossRefPubMed
11.
go back to reference Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL: Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the vesnarinone trial (vest). Circulation. 2001, 103: 2055-2059. 10.1161/01.CIR.103.16.2055.CrossRefPubMed Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL: Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the vesnarinone trial (vest). Circulation. 2001, 103: 2055-2059. 10.1161/01.CIR.103.16.2055.CrossRefPubMed
12.
go back to reference Iacobellis G, Willens HJ: Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr. 2009, 22: 1311-1319. 10.1016/j.echo.2009.10.013. quiz 1417–1318CrossRefPubMed Iacobellis G, Willens HJ: Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr. 2009, 22: 1311-1319. 10.1016/j.echo.2009.10.013. quiz 1417–1318CrossRefPubMed
13.
go back to reference Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O’Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y: Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003, 108: 2460-2466. 10.1161/01.CIR.0000099542.57313.C5.CrossRefPubMed Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O’Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y: Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003, 108: 2460-2466. 10.1161/01.CIR.0000099542.57313.C5.CrossRefPubMed
14.
go back to reference Kremen J, Dolinkova M, Krajickova J, Blaha J, Anderlova K, Lacinova Z, Haluzikova D, Bosanska L, Vokurka M, Svacina S, Haluzik M: Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab. 2006, 91: 4620-4627. 10.1210/jc.2006-1044.CrossRefPubMed Kremen J, Dolinkova M, Krajickova J, Blaha J, Anderlova K, Lacinova Z, Haluzikova D, Bosanska L, Vokurka M, Svacina S, Haluzik M: Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab. 2006, 91: 4620-4627. 10.1210/jc.2006-1044.CrossRefPubMed
15.
go back to reference Nakazato R, Dey D, Cheng VY, Gransar H, Slomka PJ, Hayes SW, Thomson LE, Friedman JD, Min JK, Berman DS: Epicardial fat volume and concurrent presence of both myocardial ischemia and obstructive coronary artery disease. Atherosclerosis. 2012, 221: 422-426. 10.1016/j.atherosclerosis.2011.12.018.CrossRefPubMed Nakazato R, Dey D, Cheng VY, Gransar H, Slomka PJ, Hayes SW, Thomson LE, Friedman JD, Min JK, Berman DS: Epicardial fat volume and concurrent presence of both myocardial ischemia and obstructive coronary artery disease. Atherosclerosis. 2012, 221: 422-426. 10.1016/j.atherosclerosis.2011.12.018.CrossRefPubMed
16.
go back to reference Cavalcante JL, Tamarappoo BK, Hachamovitch R, Kwon DH, Alraies MC, Halliburton S, Schoenhagen P, Dey D, Berman DS, Marwick TH: Association of epicardial fat, hypertension, subclinical coronary artery disease, and metabolic syndrome with left ventricular diastolic dysfunction. Am J Cardiol. 2012, 110: 1793-1798. 10.1016/j.amjcard.2012.07.045.PubMedCentralCrossRefPubMed Cavalcante JL, Tamarappoo BK, Hachamovitch R, Kwon DH, Alraies MC, Halliburton S, Schoenhagen P, Dey D, Berman DS, Marwick TH: Association of epicardial fat, hypertension, subclinical coronary artery disease, and metabolic syndrome with left ventricular diastolic dysfunction. Am J Cardiol. 2012, 110: 1793-1798. 10.1016/j.amjcard.2012.07.045.PubMedCentralCrossRefPubMed
17.
go back to reference Khawaja T, Greer C, Chokshi A, Chavarria N, Thadani S, Jones M, Schaefle K, Bhatia K, Collado JE, Shimbo D, Einstein AJ, Schulze PC: Epicardial fat volume in patients with left ventricular systolic dysfunction. Am J Cardiol. 2011, 108: 397-401. 10.1016/j.amjcard.2011.03.058.CrossRefPubMed Khawaja T, Greer C, Chokshi A, Chavarria N, Thadani S, Jones M, Schaefle K, Bhatia K, Collado JE, Shimbo D, Einstein AJ, Schulze PC: Epicardial fat volume in patients with left ventricular systolic dysfunction. Am J Cardiol. 2011, 108: 397-401. 10.1016/j.amjcard.2011.03.058.CrossRefPubMed
18.
go back to reference Wu CK, Luo JL, Tsai CT, Huang YT, Cheng CL, Lee JK, Lin LY, Lin JW, Hwang JJ, Chiang FT: Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure. Pharmacogenomics J. 2010 Feb, 10 (1): 46-53. 10.1038/tpj.2009.39.CrossRefPubMed Wu CK, Luo JL, Tsai CT, Huang YT, Cheng CL, Lee JK, Lin LY, Lin JW, Hwang JJ, Chiang FT: Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure. Pharmacogenomics J. 2010 Feb, 10 (1): 46-53. 10.1038/tpj.2009.39.CrossRefPubMed
19.
go back to reference Wu CK, Lee JK, Chiang FT, Yang CH, Huang SW, Hwang JJ, Lin JL, Tseng CD, Chen JJ, Tsai CT: Plasma levels of tumor necrosis factor-alpha and interleukin-6 are associated with diastolic heart failure through downregulation of sarcoplasmic reticulum ca2+ atpase. Crit Care Med. 2011, 39: 984-992. 10.1097/CCM.0b013e31820a91b9.CrossRefPubMed Wu CK, Lee JK, Chiang FT, Yang CH, Huang SW, Hwang JJ, Lin JL, Tseng CD, Chen JJ, Tsai CT: Plasma levels of tumor necrosis factor-alpha and interleukin-6 are associated with diastolic heart failure through downregulation of sarcoplasmic reticulum ca2+ atpase. Crit Care Med. 2011, 39: 984-992. 10.1097/CCM.0b013e31820a91b9.CrossRefPubMed
20.
go back to reference Wu CK, Tsai CT, Chang YC, Luo JL, Wang YC, Hwang JJ, Lin JL, Tseng CD, Chiang FT: Genetic polymorphisms of the angiotensin ii type 1 receptor gene and diastolic heart failure. J Hypertens. 2009, 27: 502-507. 10.1097/HJH.0b013e32831fda3a.CrossRefPubMed Wu CK, Tsai CT, Chang YC, Luo JL, Wang YC, Hwang JJ, Lin JL, Tseng CD, Chiang FT: Genetic polymorphisms of the angiotensin ii type 1 receptor gene and diastolic heart failure. J Hypertens. 2009, 27: 502-507. 10.1097/HJH.0b013e32831fda3a.CrossRefPubMed
21.
go back to reference Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986, 57: 450-458. 10.1016/0002-9149(86)90771-X.CrossRefPubMed Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986, 57: 450-458. 10.1016/0002-9149(86)90771-X.CrossRefPubMed
22.
go back to reference Malavazos AE, Di Leo G, Secchi F, Lupo EN, Dogliotti G, Coman C, Morricone L, Corsi MM, Sardanelli F, Iacobellis G: Relation of echocardiographic epicardial fat thickness and myocardial fat. Am J Cardiol. 2010, 105: 1831-1835. 10.1016/j.amjcard.2010.01.368.CrossRefPubMed Malavazos AE, Di Leo G, Secchi F, Lupo EN, Dogliotti G, Coman C, Morricone L, Corsi MM, Sardanelli F, Iacobellis G: Relation of echocardiographic epicardial fat thickness and myocardial fat. Am J Cardiol. 2010, 105: 1831-1835. 10.1016/j.amjcard.2010.01.368.CrossRefPubMed
23.
go back to reference Hirota H, Yoshida K, Kishimoto T, Taga T: Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci U S A. 1995, 92: 4862-4866. 10.1073/pnas.92.11.4862.PubMedCentralCrossRefPubMed Hirota H, Yoshida K, Kishimoto T, Taga T: Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci U S A. 1995, 92: 4862-4866. 10.1073/pnas.92.11.4862.PubMedCentralCrossRefPubMed
24.
go back to reference Fernstrom A, Hylander B, Moritz A, Jacobsson H, Rossner S: Increase of intra-abdominal fat in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int. 1998, 18: 166-171.PubMed Fernstrom A, Hylander B, Moritz A, Jacobsson H, Rossner S: Increase of intra-abdominal fat in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int. 1998, 18: 166-171.PubMed
25.
go back to reference Marchington JM, Mattacks CA, Pond CM: Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B. 1989, 94: 225-232. 10.1016/0300-9629(89)90540-9.CrossRefPubMed Marchington JM, Mattacks CA, Pond CM: Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B. 1989, 94: 225-232. 10.1016/0300-9629(89)90540-9.CrossRefPubMed
26.
go back to reference lacobellis G, Corradi D, Sharma AM: Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005, 2: 536-543. 10.1038/ncpcardio0319.CrossRef lacobellis G, Corradi D, Sharma AM: Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005, 2: 536-543. 10.1038/ncpcardio0319.CrossRef
28.
go back to reference Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, Laing I, Yates AP, Pemberton PW, Malik RA, Heagerty AM: Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation. 2009, 119: 1661-1670. 10.1161/CIRCULATIONAHA.108.821181.CrossRefPubMed Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, Laing I, Yates AP, Pemberton PW, Malik RA, Heagerty AM: Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation. 2009, 119: 1661-1670. 10.1161/CIRCULATIONAHA.108.821181.CrossRefPubMed
29.
go back to reference Pang C, Gao Z, Yin J, Zhang J, Jia W, Ye J: Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. Am J Physiol Endocrinol Metab. 2008, 295: E313-E322. 10.1152/ajpendo.90296.2008.PubMedCentralCrossRefPubMed Pang C, Gao Z, Yin J, Zhang J, Jia W, Ye J: Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. Am J Physiol Endocrinol Metab. 2008, 295: E313-E322. 10.1152/ajpendo.90296.2008.PubMedCentralCrossRefPubMed
30.
go back to reference Henrichot E, Juge-Aubry CE, Pernin A, Pache JC, Velebit V, Dayer JM, Meda P, Chizzolini C, Meier CA: Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?. Arterioscler Thromb Vasc Biol. 2005, 25: 2594-2599. 10.1161/01.ATV.0000188508.40052.35.CrossRefPubMed Henrichot E, Juge-Aubry CE, Pernin A, Pache JC, Velebit V, Dayer JM, Meda P, Chizzolini C, Meier CA: Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?. Arterioscler Thromb Vasc Biol. 2005, 25: 2594-2599. 10.1161/01.ATV.0000188508.40052.35.CrossRefPubMed
31.
go back to reference Iozzo P, Lautamaki R, Borra R, Lehto HR, Bucci M, Viljanen A, Parkka J, Lepomaki V, Maggio R, Parkkola R, Knuuti J, Nuutila P: Contribution of glucose tolerance and gender to cardiac adiposity. J Clin Endocrinol Metab. 2009, 94: 4472-4482. 10.1210/jc.2009-0436.CrossRefPubMed Iozzo P, Lautamaki R, Borra R, Lehto HR, Bucci M, Viljanen A, Parkka J, Lepomaki V, Maggio R, Parkkola R, Knuuti J, Nuutila P: Contribution of glucose tolerance and gender to cardiac adiposity. J Clin Endocrinol Metab. 2009, 94: 4472-4482. 10.1210/jc.2009-0436.CrossRefPubMed
32.
go back to reference Kankaanpaa M, Lehto HR, Parkka JP, Komu M, Viljanen A, Ferrannini E, Knuuti J, Nuutila P, Parkkola R, Iozzo P: Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab. 2006, 91: 4689-4695. 10.1210/jc.2006-0584.CrossRefPubMed Kankaanpaa M, Lehto HR, Parkka JP, Komu M, Viljanen A, Ferrannini E, Knuuti J, Nuutila P, Parkkola R, Iozzo P: Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab. 2006, 91: 4689-4695. 10.1210/jc.2006-0584.CrossRefPubMed
33.
go back to reference Baker AR, Harte AL, Howell N, Pritlove DC, Ranasinghe AM, Da Silva NF, Youssef EM, Khunti K, Davies MJ, Bonser RS, Kumar S, Pagano D, McTernan PG: Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease. J Clin Endocrinol Metab. 2009, 94: 261-267.CrossRefPubMed Baker AR, Harte AL, Howell N, Pritlove DC, Ranasinghe AM, Da Silva NF, Youssef EM, Khunti K, Davies MJ, Bonser RS, Kumar S, Pagano D, McTernan PG: Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease. J Clin Endocrinol Metab. 2009, 94: 261-267.CrossRefPubMed
34.
go back to reference Hirata Y, Kurobe H, Akaike M, Chikugo F, Hori T, Bando Y, Nishio C, Higashida M, Nakaya Y, Kitagawa T, Sata M: Enhanced inflammation in epicardial fat in patients with coronary artery disease. Int Heart J. 2011, 52: 139-142. 10.1536/ihj.52.139.CrossRefPubMed Hirata Y, Kurobe H, Akaike M, Chikugo F, Hori T, Bando Y, Nishio C, Higashida M, Nakaya Y, Kitagawa T, Sata M: Enhanced inflammation in epicardial fat in patients with coronary artery disease. Int Heart J. 2011, 52: 139-142. 10.1536/ihj.52.139.CrossRefPubMed
35.
go back to reference Hirata Y, Tabata M, Kurobe H, Motoki T, Akaike M, Nishio C, Higashida M, Mikasa H, Nakaya Y, Takanashi S, Igarashi T, Kitagawa T, Sata M: Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol. 2011, 58: 248-255. 10.1016/j.jacc.2011.01.048.CrossRefPubMed Hirata Y, Tabata M, Kurobe H, Motoki T, Akaike M, Nishio C, Higashida M, Mikasa H, Nakaya Y, Takanashi S, Igarashi T, Kitagawa T, Sata M: Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol. 2011, 58: 248-255. 10.1016/j.jacc.2011.01.048.CrossRefPubMed
36.
go back to reference Atalar F, Gormez S, Caynak B, Akan G, Tanriverdi G, Bilgic-Gazioglu S, Gunay D, Duran C, Akpinar B, Ozbek U, Buyukdevrim AS, Yazici Z: The role of mediastinal adipose tissue 11beta-hydroxysteroid d ehydrogenase type 1 and glucocorticoid expression in the development of coronary atherosclerosis in obese patients with ischemic heart disease. Cardiovasc Diabetol. 2012, 11: 115-10.1186/1475-2840-11-115.PubMedCentralCrossRefPubMed Atalar F, Gormez S, Caynak B, Akan G, Tanriverdi G, Bilgic-Gazioglu S, Gunay D, Duran C, Akpinar B, Ozbek U, Buyukdevrim AS, Yazici Z: The role of mediastinal adipose tissue 11beta-hydroxysteroid d ehydrogenase type 1 and glucocorticoid expression in the development of coronary atherosclerosis in obese patients with ischemic heart disease. Cardiovasc Diabetol. 2012, 11: 115-10.1186/1475-2840-11-115.PubMedCentralCrossRefPubMed
37.
go back to reference Kim HM, Kim KJ, Lee HJ, Yu HT, Moon JH, Kang ES, Cha BS, Lee HC, Lee BW, Kim YJ: Epicardial adipose tissue thickness is an indicator for coronary artery stenosis in asymptomatic type 2 diabetic patients: its assessment by cardiac magnetic resonance. Cardiovasc Diabetol. 2012, 11: 83-10.1186/1475-2840-11-83.PubMedCentralCrossRefPubMed Kim HM, Kim KJ, Lee HJ, Yu HT, Moon JH, Kang ES, Cha BS, Lee HC, Lee BW, Kim YJ: Epicardial adipose tissue thickness is an indicator for coronary artery stenosis in asymptomatic type 2 diabetic patients: its assessment by cardiac magnetic resonance. Cardiovasc Diabetol. 2012, 11: 83-10.1186/1475-2840-11-83.PubMedCentralCrossRefPubMed
38.
go back to reference Dagvasumberel M, Shimabukuro M, Nishiuchi T, Ueno J, Takao S, Fukuda D, Hirata Y, Kurobe H, Soeki T, Iwase T, Kusunose K, Niki T, Yamaguchi K, Taketani Y, Yagi S, Tomita N, Yamada H, Wakatsuki T, Harada M, Kitagawa T, Sata M: Gender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: A 3-dimensional cardiac computed tomography imaging study in japanese subjects. Cardiovasc Diabetol. 2012, 11: 106-10.1186/1475-2840-11-106.PubMedCentralCrossRefPubMed Dagvasumberel M, Shimabukuro M, Nishiuchi T, Ueno J, Takao S, Fukuda D, Hirata Y, Kurobe H, Soeki T, Iwase T, Kusunose K, Niki T, Yamaguchi K, Taketani Y, Yagi S, Tomita N, Yamada H, Wakatsuki T, Harada M, Kitagawa T, Sata M: Gender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: A 3-dimensional cardiac computed tomography imaging study in japanese subjects. Cardiovasc Diabetol. 2012, 11: 106-10.1186/1475-2840-11-106.PubMedCentralCrossRefPubMed
39.
go back to reference van der Meer RW, Rijzewijk LJ, Diamant M, Hammer S, Schar M, Bax JJ, Smit JW, Romijn JA, de Roos A, Lamb HJ: The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function. Eur Heart J. 2008, 29: 1516-1522. 10.1093/eurheartj/ehn207.CrossRefPubMed van der Meer RW, Rijzewijk LJ, Diamant M, Hammer S, Schar M, Bax JJ, Smit JW, Romijn JA, de Roos A, Lamb HJ: The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function. Eur Heart J. 2008, 29: 1516-1522. 10.1093/eurheartj/ehn207.CrossRefPubMed
40.
go back to reference Iacobellis G, Leonetti F, Singh N, Sharma AM: Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. Int J Cardiol. 2007, 115: 272-273. 10.1016/j.ijcard.2006.04.016.CrossRefPubMed Iacobellis G, Leonetti F, Singh N, Sharma AM: Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. Int J Cardiol. 2007, 115: 272-273. 10.1016/j.ijcard.2006.04.016.CrossRefPubMed
41.
go back to reference Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992, 257: 387-389. 10.1126/science.1631560.CrossRefPubMed Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992, 257: 387-389. 10.1126/science.1631560.CrossRefPubMed
42.
go back to reference Lee JK, Lin HH, Tsai CT, Chen JJ, Kuo CC, Lien YC, Lin JW, Huang JW, Hwang SW, Hwang JJ, Tseng CD, Chiang FT, Wu CK: Differential association of proinflammatory cytokines with left ventricular diastolic dysfunction in subjects with and without continuous ambulatory peritoneal dialysis. Nutr Metab Cardiovasc Dis. 2012, 22: 974-980. 10.1016/j.numecd.2011.01.001.CrossRefPubMed Lee JK, Lin HH, Tsai CT, Chen JJ, Kuo CC, Lien YC, Lin JW, Huang JW, Hwang SW, Hwang JJ, Tseng CD, Chiang FT, Wu CK: Differential association of proinflammatory cytokines with left ventricular diastolic dysfunction in subjects with and without continuous ambulatory peritoneal dialysis. Nutr Metab Cardiovasc Dis. 2012, 22: 974-980. 10.1016/j.numecd.2011.01.001.CrossRefPubMed
Metadata
Title
Accumulation of epicardial fat rather than visceral fat is an independent risk factor for left ventricular diastolic dysfunction in patients undergoing peritoneal dialysis
Authors
Heng-Hsu Lin
Jen-Kuang Lee
Chung-Yi Yang
Yu-Chung Lien
Jenq-Wen Huang
Cho-Kai Wu
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2013
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-12-127

Other articles of this Issue 1/2013

Cardiovascular Diabetology 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.